These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30956042)

  • 1. Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients.
    Megaly M; Ali A; Abraham B; Khalil C; Zordok M; Shaker M; Tawadros M; Hennawy BS; Elbadawi A; Omer M; Saad M
    Cardiovasc Revasc Med; 2020 Jan; 21(1):78-85. PubMed ID: 30956042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes with drug-coated balloons in small-vessel coronary artery disease.
    Megaly M; Rofael M; Saad M; Rezq A; Kohl LP; Kalra A; Shishehbor M; Soukas P; Abbott JD; Brilakis ES
    Catheter Cardiovasc Interv; 2019 Apr; 93(5):E277-E286. PubMed ID: 30489687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials.
    Sedhom R; Hamed M; Elbadawi A; Mohsen A; Swamy P; Athar A; Bharadwaj AS; Prasad V; Elgendy IY; Alfonso F
    JACC Cardiovasc Interv; 2024 Jul; 17(13):1533-1543. PubMed ID: 38986653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.
    Kokkinidis DG; Prouse AF; Avner SJ; Lee JM; Waldo SW; Armstrong EJ
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):285-299. PubMed ID: 29024274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical safety and efficacy of drug-coated balloon in the treatment of in-stent restenosis: A meta-analysis and systematic review.
    Xi Y; Chen J; Bi Y; Xie S; Liao T; Zhang Y; Kislauskis E; Wu T; Laham R; Xiao J
    Catheter Cardiovasc Interv; 2020 Aug; 96(2):E129-E141. PubMed ID: 31714010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of drug-coated balloon angioplasty in early versus late occurring drug-eluting stent restenosis: A pooled analysis from the randomized ISAR DESIRE 3 and DESIRE 4 trials.
    Koch T; Cassese S; Xhepa E; Mayer K; Tölg R; Hoppmann P; Laugwitz KL; Byrne RA; Kastrati A; Kufner S
    Catheter Cardiovasc Interv; 2020 Nov; 96(5):1008-1015. PubMed ID: 31789486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease.
    Costopoulos C; Latib A; Naganuma T; Sticchi A; Figini F; Basavarajaiah S; Carlino M; Chieffo A; Montorfano M; Naim C; Kawaguchi M; Giannini F; Colombo A
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1153-9. PubMed ID: 24262615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-eluting balloons in the treatment of de-novo coronary lesions: a meta-analysis of randomized-controlled trials.
    Li Y; Wang C; Zuo G; Wang K; Cao Z; Du X
    Coron Artery Dis; 2016 Sep; 27(6):467-77. PubMed ID: 27100660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and Angiographic Outcomes With Drug-Coated Balloons for De Novo Coronary Lesions: A Meta-Analysis of Randomized Clinical Trials.
    Elgendy IY; Gad MM; Elgendy AY; Mahmoud A; Mahmoud AN; Cuesta J; Rivero F; Alfonso F
    J Am Heart Assoc; 2020 May; 9(10):e016224. PubMed ID: 32410493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Drug-Eluting Balloons for Patients With In-Stent Restenosis: A Meta-Analysis of 8 Randomized Controlled Trials.
    Gao S; Shen J; Mukku VK; Wang MJ; Akhtar M; Liu W
    Angiology; 2016 Aug; 67(7):612-21. PubMed ID: 26483569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits with drug-coated balloon as compared to a conventional revascularization strategy for the treatment of coronary and non-coronary arterial disease: a comprehensive meta-analysis of 45 randomized trials.
    Verdoia M; Negro F; Kedhi E; Suryapranata H; Marcolongo M; De Luca G
    Vascul Pharmacol; 2021 Jun; 138():106859. PubMed ID: 33819672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
    Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Treatment and Outcomes of Small Coronary Vessels: A SCAAR Report.
    Silverio A; Buccheri S; Venetsanos D; Alfredsson J; Lagerqvist B; Persson J; Witt N; James S; Sarno G
    JACC Cardiovasc Interv; 2020 Apr; 13(7):793-804. PubMed ID: 32061601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Coated Balloons Versus Second-Generation Drug-Eluting Stents for the Management of Recurrent Multimetal-Layered In-Stent Restenosis.
    Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Mangieri A; Contri R; Stella S; Figini F; Chieffo A; Carlino M; Montorfano M; Colombo A
    JACC Cardiovasc Interv; 2015 Oct; 8(12):1586-94. PubMed ID: 26386758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.
    Oh PC; Suh SY; Kang WC; Lee K; Han SH; Ahn T; Shin EK
    Korean J Intern Med; 2016 May; 31(3):501-6. PubMed ID: 26951915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of drug-eluting balloon versus drug-eluting stent for treatment of coronary artery disease: a meta-analysis of randomized controlled trials.
    Liu L; Liu B; Ren J; Hui G; Qi C; Wang J
    BMC Cardiovasc Disord; 2018 Mar; 18(1):46. PubMed ID: 29499651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of clinical outcomes of two different types of paclitaxel-coated balloons for treatment of patients with coronary in-stent restenosis.
    Nguyen VPT; Kim C; Hong SJ; Ahn CM; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
    Heart Vessels; 2019 Sep; 34(9):1420-1428. PubMed ID: 30903315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of drug-eluting stent restenosis: Comparison between drug-eluting balloon versus second-generation drug-eluting stents from a retrospective observational study.
    Basavarajaiah S; Naganuma T; Latib A; Sticchi A; Ciconte G; Panoulas V; Chieffo A; Montorfano M; Carlino M; Colombo A
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):522-528. PubMed ID: 26715370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.